Dr. Nabil Saba is a professor and vice chair for quality and safety at Emory University’s department of hematology and medical oncology and holds a joint appointment as a professor of otolaryngology at Emory University School of Medicine. He serves as the director of the head and neck oncology program and leads the head and neck working group at Winship Cancer Institute at Emory University. He is a recognized expert in head and neck cancer immunotherapy, focusing his work on translational research and the study and development of novel therapeutics in head and neck and esophageal cancer. Dr. Saba leads several clinical trials with a focus on biomarker endpoints and has received NIH funding to examine novel genomic approaches for diagnosing HPV positive oropharyngeal cancers. He has chaired the Head and Neck Cancer NCI Steering Committee’s Rare Tumors Task Forces. Dr. Saba is an appointed member of the ASCO Clinical Guidelines Committee as well as the ASCO Head and Neck Guideline Advisory Group.